4 , 2011 / PRNewswire / -- PneumRx , Inc . ( www.pneumrx.com ) , a medical device company dedicated to bringing innovation and improvements to the treatment of lung disease , today announced that it has raised $ 33 million in working capital commitments . � � The oversubscribed round was led by Forbion Capital Partners and co-led by Endeavour Vision , both leading venture capital firms from Europe , and also included a prominent strategic corporate partner . � � The syndicate was joined by existing investors Adams Street Partners , Telegraph Hill Partners , Alta Partners , and Spray Venture Partners , among others . � � Silicon Valley Bank and Leader Ventures also contributed to the capital raise in PneumRx .